NBIX Neurocrine Biosciences

• None no insider bought on the open market
• None no sales outside a trading plan
• $77.8M sold by 15 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. David W. Boyer Chief Corp. Affairs Officer
   Planned sale
   $130K 826 shares at $157.45 8.7% of stake
   Traded Sep 14 Filed Sep 15
   ↗
3. Matt Abernethy CFO
   Planned sale
   $363K 2,311 shares at $157.20 5.1% of stake
   Traded Sep 14 Filed Sep 15
   ↗
4. Eric Benevich Chief Commercial Officer
   Planned sale
   $333K 2,154 shares at $154.61 3.2% of stake
   Traded Sep 9 Filed Sep 10
   ↗
5. Leslie V Norwalk Director
   Planned sale
   $228K 1,250 shares at $182.01 44% of stake
   Traded Jul 28 Filed Jul 30
   ↗
6. Ingrid Delaet Chief Regulatory Officer
   Planned sale
   $791K 4,367 shares at $181.02 21% of stake
   Traded Jul 10 Filed Jul 13
   ↗
7. Darin Lippoldt Chief Legal Officer
   Planned sale
   $1.8M 10,000 shares at $179.60 15% of stake
   Traded Jul 9 Filed Jul 13
   ↗
8. Ingrid Delaet Chief Regulatory Officer
   Planned sale
   $2.6M 14,571 shares at $178.65 47% of stake
   Traded Jul 7–9 Filed Jul 9
   ↗
9. Darin Lippoldt Chief Legal Officer
   Planned sale
   $1.7M 10,000 shares at $170.15 15% of stake
   Traded Jun 26–29 Filed Jun 30
   ↗
10. Stephen A Sherwin Director
    Planned sale
    $4.1M 25,000 shares at $165.32 61% of stake
    Traded Jun 5 Filed Jun 9
    ↗
11. Leslie V Norwalk Director
    Planned sale
    $210K 1,250 shares at $168.06 31% of stake
    Traded Jun 4 Filed Jun 8
    ↗
12. Julie Cooke Chief Human Resources Officer
    Planned sale
    $5.8M 36,937 shares at $156.22 62% of stake
    Traded Jun 2 Filed Jun 4
    ↗
13. Ingrid Delaet Chief Regulatory Officer
    Planned sale
    $354K 2,261 shares at $156.71 12% of stake
    Traded May 29 Filed Jun 2
    ↗
14. Jude Onyia Chief Scientific Officer
    Planned sale
    $1.8M 11,000 shares at $160.25 30% of stake
    Traded Jun 1 Filed Jun 2
    ↗
15. Jude Onyia Chief Scientific Officer
    Planned sale
    $1.7M 11,000 shares at $155.53 30% of stake
    Traded May 27 Filed May 29
    ↗
16. David W. Boyer Chief Corp. Affairs Officer
    Planned sale
    $609K 3,888 shares at $156.64 33% of stake
    Traded May 26 Filed May 28
    ↗

Also filed in the last 12 months, not counted as buying or selling: 75 option exercises, 57 share withholdings for taxes, 20 stock grants, 6 gifts, and 1 sale to cover taxes.